Lexaria Bioscience Corp (LEXX)
2.35
+0.16
(+7.31%)
USD |
NASDAQ |
Apr 26, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Free Cash Flow (Quarterly): -0.6766M for Feb. 29, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -0.6766M |
| November 30, 2023 | -1.222M |
| August 31, 2023 | -1.690M |
| May 31, 2023 | -1.820M |
| February 28, 2023 | -1.261M |
| November 30, 2022 | -1.280M |
| August 31, 2022 | -1.227M |
| May 31, 2022 | -1.297M |
| February 28, 2022 | -1.312M |
| November 30, 2021 | -1.224M |
| August 31, 2021 | -1.112M |
| May 31, 2021 | -1.227M |
| February 28, 2021 | -0.9142M |
| November 30, 2020 | -0.8153M |
| August 31, 2020 | -0.653M |
| May 31, 2020 | -0.6848M |
| February 29, 2020 | -0.7539M |
| November 30, 2019 | -0.5608M |
| August 31, 2019 | -0.7697M |
| May 31, 2019 | -1.341M |
| February 28, 2019 | -0.9329M |
| November 30, 2018 | -0.7315M |
| August 31, 2018 | -0.8638M |
| May 31, 2018 | -0.5863M |
| February 28, 2018 | -0.6172M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.536M |
| August 31, 2017 | -0.3533M |
| May 31, 2017 | -0.6035M |
| February 28, 2017 | -0.4841M |
| November 30, 2016 | -0.1147M |
| August 31, 2016 | -0.2655M |
| May 31, 2016 | -0.1086M |
| February 29, 2016 | -0.0948M |
| November 30, 2015 | -0.212M |
| August 31, 2015 | -0.5769M |
| May 31, 2015 | -0.427M |
| February 28, 2015 | -0.3609M |
| November 30, 2014 | -0.1732M |
| July 31, 2014 | -0.2229M |
| April 30, 2014 | -0.1283M |
| January 31, 2014 | -0.1169M |
| October 31, 2013 | 0.047M |
| July 31, 2013 | 0.0602M |
| April 30, 2013 | 0.0968M |
| January 31, 2013 | 0.0253M |
| October 31, 2012 | 0.1766M |
| July 31, 2012 | -0.1541M |
| April 30, 2012 | -0.0699M |
| January 31, 2012 | -0.0907M |
| October 31, 2011 | -0.4286M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.820M
Minimum
May 2023
-0.5608M
Maximum
Nov 2019
-1.092M
Average
-1.223M
Median
Free Cash Flow (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 14.25M |
| Sunshine Biopharma Inc | -2.993M |
| Acasti Pharma Inc | -1.892M |
| Edesa Biotech Inc | -1.406M |
| Xenon Pharmaceuticals Inc | -35.54M |